Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-specific reference ranges for serum prostate-specific antigen.

J E Oesterling1

  • 1Professor and Urologist-in-Chief, Director, The Michigan Prostate Center, The University of Michigan, Ann Arbor, Michigan.

The Canadian Journal of Urology
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.

The Journal of urology·1999
Same author

Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

The Journal of urology·1999
Same author

Have complication rates decreased after treatment for localized prostate cancer?

The Journal of urology·1999
Same author

Reference ranges for serum prostate-specific antigen in black and white men without cancer.

Urology·1998
Same author

Understanding artificial neural networks and exploring their potential applications for the practicing urologist.

Urology·1998
Same author

Screening digital rectal examination and prostate cancer mortality: a population-based case-control study.

Urology·1998
Same journal

Clean intermittent catheterization reverses hydronephrosis in a child with congenital nephrogenic diabetes insipidus: a case report.

The Canadian journal of urology·2026
Same journal

Penile ring strangulation injury, what to do when the bolt cutters don't work: a case report.

The Canadian journal of urology·2026
Same journal

Prostatic tuberculosis incidentally discovered during transurethral resection of prostate with subsequent diagnosis of rectal and pulmonary involvement: a case report.

The Canadian journal of urology·2026
Same journal

Early clinical experience and learning curve of transperineal prostate biopsy with a novel angle-adjustable needle guide.

The Canadian journal of urology·2026
Same journal

Same-day surgical cancellations in pediatric urology: identifying trends for quality improvement.

The Canadian journal of urology·2026
Same journal

Clinical evaluation and related factor analysis of intrarenal pressure using a Chinese-made disposable pressure-measuring flexible ureteroscope.

The Canadian journal of urology·2026
See all related articles

Prostate-specific antigen (PSA) is a glycoprotein crucial for diagnosing and managing prostate cancer. Advances in understanding PSA density, velocity, molecular forms, and age-dependency enhance its clinical utility for early cancer detection.

Area of Science:

  • Biochemistry and Molecular Biology
  • Oncology
  • Urology

Background:

  • Prostate-specific antigen (PSA) is a glycoprotein with established roles in prostate cancer diagnostics.
  • Understanding the biomolecular properties and physiology of PSA is key to improving its clinical applications.
  • Current research focuses on refining PSA's utility beyond basic detection.

Purpose of the Study:

  • To explore how recent scientific advances enhance the clinical usefulness of prostate-specific antigen (PSA).
  • To highlight the impact of new PSA-related concepts on prostate cancer diagnosis and management.
  • To discuss the potential of novel PSA discoveries for early prostate cancer detection.

Main Methods:

  • Review of recent scientific literature on prostate-specific antigen (PSA).

Related Experiment Videos

  • Analysis of emerging concepts such as PSA density and PSA velocity.
  • Examination of research on the molecular forms and age-dependent variations of serum PSA.

    • Main Results:

    • Development of PSA density and velocity concepts improves clinical utility.
    • Discovery of multiple molecular forms of PSA in serum offers enhanced diagnostic potential.
    • Identification of age-dependency in serum PSA levels provides new avenues for early detection.

    Conclusions:

    • Continued research into PSA's biomolecular properties and physiology will further improve its clinical value.
    • Advances like PSA density, velocity, and understanding its molecular forms significantly enhance its utility.
    • Age-specific PSA analysis holds promise for improving early prostate cancer detection strategies.